The effects of diurnal intermittent fasting on the wake-promoting neurotransmitter orexin-A

被引:26
|
作者
Almeneessier, Aljohara S. [1 ]
Alzoghaibi, Mohammed [2 ]
BaHammam, Abdulrahman A. [3 ]
Ibrahim, Mahmoud G. [3 ]
Olaish, Awad H. [4 ]
Nashwan, Samar Z. [4 ]
BaHammam, Ahmed S. [4 ]
机构
[1] King Saud Univ, Dept Family Med, Coll Med, Riyadh, Saudi Arabia
[2] King Saud Univ, Dept Physiol, Coll Med, Riyadh, Saudi Arabia
[3] Manarat Al Riyadh Sch, King Abdulaziz & His Compan Fdn Giftedness & Crea, King, WI USA
[4] King Saud Univ, Univ Sleep Disorders Ctr, Coll Med, Box 225503, Riyadh 11324, Saudi Arabia
关键词
Hypocretin; intermittent fasting; orexin; Ramadan; sleep; vigilance; OBSTRUCTIVE SLEEP-APNEA; ENERGY-EXPENDITURE; DAYTIME SLEEPINESS; RAMADAN; PATTERNS; NEUROPEPTIDES; CHRONOTYPE; ARMBAND; HUMANS; SYSTEM;
D O I
10.4103/atm.ATM_181_17
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Food restriction has been demonstrated to increase the alertness in different species and to increase the levels of the wake-promoting neurotransmitter orexin. We hypothesized that diurnal intermittent fasting (DIF) increases orexin-A levels during fasting. Therefore, we conducted this study to assess the effects of DIF, during the month of Ramadan, on orexin, while controlling for lifestyle changes that may accompany Ramadan such as sleep duration, bedtime and wake time, energy expenditure, light exposure, and food. METHODS: Eight young healthy volunteers (mean age, 25.4 +/- 3.5 years) reported to the laboratory on three occasions: (1) 4 weeks before Ramadan while performing DIF for 1 week outside the month of Ramadan (fasting outside Ramadan); (2) 1 week before Ramadan (nonfasting baseline) (BL); and (3) during the 2nd week of Ramadan while performing DIF (Ramadan). Plasma levels of orexin-A were measured using an enzyme immunoassay five times at 22:00, 02:00, 04:00, 06:00, and 11:00. Caloric intake, light exposure, and sleep schedule were maintained during the participants' stays in the laboratory in the three study periods. RESULTS: Orexin-A levels increased in the daytime during fasting and decreased at night compared to BL. The differences in orexin-A levels between DIF and BL were significant at 06:00, 11:00, 22:00, and 02:00. CONCLUSIONS: DIF increases orexin-A levels in the plasma during fasting hours. This finding supports findings from animal studies showing that fasting increases alertness.
引用
收藏
页码:48 / 54
页数:7
相关论文
共 43 条
  • [31] JZP-110, a Dopamine Norepinephrine Reuptake Inhibitor (DNRI), with Robust Wake-Promoting Effects and Low Abuse Potential
    Baladi, Michelle
    Black, Jed
    Carter, Lawrence P.
    [J]. ANNALS OF NEUROLOGY, 2016, 80 : S165 - S166
  • [32] WAKE PROMOTING EFFECTS OF SELECTIVE ADENOSINE RECEPTOR ANTAGONISTS IN OREXIN/ATAXIN-3 NARCOLEPTIC MICE
    Song, Y.
    Soya, A.
    Okuro, M.
    Nishino, S.
    [J]. SLEEP, 2010, 33 : A54 - A54
  • [33] A systematic review and activation likelihood estimation meta-analysis of fMRI studies on arousing or wake-promoting effects in Buddhist meditation
    Chaudhary, Inder S.
    Shyi, Gary Chon-Wen
    Huang, Shih-Tseng Tina
    [J]. FRONTIERS IN PSYCHOLOGY, 2023, 14
  • [34] Wake-promoting effects of ONO-4127, a prostaglandin DP1 receptor antagonist, in hypocretin deficient narcoleptic mice
    Sagawa, Y.
    Sakai, N.
    Chikahisa, S.
    Sato, M.
    Chiba, S.
    Nishino, S.
    [J]. JOURNAL OF SLEEP RESEARCH, 2012, 21 : 266 - 266
  • [35] Effects of Diurnal Ramadan Intermittent Fasting on Cardiometabolic Risk Factors and Sleep Quality in Healthy Turkish Adults
    Celik, Ozge Mengi
    Kocak, Tevfik
    Koksal, Eda
    [J]. ECOLOGY OF FOOD AND NUTRITION, 2022, 61 (05) : 595 - 607
  • [36] The effects of Ramadan intermittent fasting on sleep-wake behaviour and daytime sleepiness in team sport referees
    Trabelsi, Khaled
    Masmoudi, Liwa
    Ammar, Achraf
    Boukhris, Omar
    Khacharem, Aimen
    Jemal, Mohamed
    Zlitni, Sahar
    Bragazzi, Nicola Luigi
    Clark, Cain C. T.
    Lastella, Michele
    Chtourou, Hamdi
    [J]. JOURNAL OF SPORTS SCIENCES, 2021, 39 (21) : 2411 - 2417
  • [37] Hemodynamic and Cardiac Neurotransmitter-releasing Effects in Conscious Dogs of Attention- and Wake-promoting Agents: A Comparison of d-Amphetamine, Atomoxetine, Modafinil, and a Novel Quinazolinone H3 Inverse Agonist
    Lynch, Joseph, Jr.
    Regan, Christopher
    Stump, Gao
    Tannenbaum, Pamela
    Stevens, Joanne
    Bone, Ashleigh
    Gilberto, David
    Johnson, Colena
    Fujino, Naoko
    Takenaga, Norihiro
    Tokita, Shigeru
    Nagase, Tsuyoshi
    Sato, Nagaaki
    Renger, John
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2009, 53 (01) : 52 - 59
  • [38] Wake promoting effects of thioperamide, a histamine H3 antagonist in orexin/ataxin-3 narcoleptic mice
    Shiba, T
    Fujiki, N
    Wisor, JP
    Dale, EM
    Sakurai, T
    Nishino, S
    [J]. SLEEP, 2004, 27 : 241 - 242
  • [39] JZP-110, a dopamine-norepinephrine reuptake inhibitor with wake-promoting effects, has low abuse potential: in vitro and in vivo studies
    Baladi, M.
    Black, J.
    Carter, L. P.
    [J]. JOURNAL OF SLEEP RESEARCH, 2016, 25 : 146 - 146
  • [40] Wake-Promoting and EEG Spectral Effects of Modafinil After Acute or Chronic Administration in the R6/2 Mouse Model of Huntington's Disease
    Vas, Szilvia
    Casey, Jackie M.
    Schneider, Will T.
    Kalmar, Lajos
    Morton, A. Jennifer
    [J]. NEUROTHERAPEUTICS, 2020, 17 (03) : 1075 - 1086